CASI Pharmaceuticals (NASDAQ:CASI) Research Coverage Started at StockNews.com : vimarsana.com

StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note published on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $10.00 price target on shares of CASI Pharmaceuticals in a research note on Monday, […]

Related Keywords

Wellington , New Zealand General , New Zealand , United States , , Renaissance Technologies , Pharmaceuticals Daily , Pharmaceuticals Inc , Pharmaceuticals Price Performance , Virtu Financial , Citigroup Inc , Wellington Shields Co , Susquehanna International Group , Free Report , Get Free Report , International Group , Wellington Shields , Casi Pharmaceuticals , Nasdaq Casi , Casi , Medical , Initiated Coverage , Stocknews Com ,